Authors:
Kushner, BH
Cheung, NKV
Kramer, K
Dunkel, IJ
Calleja, E
Boulad, F
Citation: Bh. Kushner et al., Topotecan combined with myeloablative doses of thiotepa and carboplatin for neuroblastoma, brain tumors, and other poor-risk solid tumors in childrenand young adults, BONE MAR TR, 28(6), 2001, pp. 551-556
Authors:
Yan, Y
Dunkel, IJ
Guan, X
Abramson, DH
Jhanwar, SC
O'Reilly, RJ
Citation: Y. Yan et al., Engraftment and growth of patient-derived retinoblastoma tumour in severe combined immunodeficiency mice, EUR J CANC, 36(2), 2000, pp. 221-228
Authors:
Papadakis, V
Dunkel, IJ
Cramer, LD
Kramer, E
Papadopoulos, E
Goldman, S
Packer, RJ
Willoughby, M
Baker, D
Garvin, J
Strandjord, S
Coccia, P
Kaplan, AM
Klemperer, M
Finlay, JL
Citation: V. Papadakis et al., High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors, BONE MAR TR, 26(2), 2000, pp. 153-160
Citation: Dh. Abramson et al., A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma, OPHTHALMOL, 106(10), 1999, pp. 1947-1950
Authors:
Collins, JJ
Dunkel, IJ
Gupta, SK
Inturrisi, CE
Lapin, J
Palmer, LN
Weinstein, SM
Portenoy, RK
Citation: Jj. Collins et al., Transdermal fentanyl in children with cancer pain: Feasibility, tolerability, and pharmacokinetic correlates, J PEDIAT, 134(3), 1999, pp. 319-323